The board of directors of Angelalign Technology Inc. announced that Mr. ZHOU Hao has been appointed as an independent non-executive Director, the chairman of the audit committee of the Company, a member of each of the nomination committee of the Company and the remuneration committee of the Company, all with effect from April 11, 2023. Mr. Zhou, aged 46, was appointed as an independent non-executive Director, the chairman of the Audit Committee and a member of each of the Nomination Committee and Remuneration Committee of the Company with effect from April 11, 2023. Mr. Zhou has served as an independent non-executive director of Meitu Inc. since November 2016 and an independent non-executive director of Bairong Inc. since March 2021.

From June 2011 to September 2019, Mr. Zhou was the chief financial officer of 58.com Inc. and was subsequently re-designated as the head of international business in September 2019 and the chief strategic officer in April 2020. In November 2020, he was redesignated as the chief strategy officer of Anjuke and served the role until March 2023. Prior to that, in September 2010, Mr. Zhou joined CITIC Pharmaceutical Co Ltd. as the chief financial officer.

From May 2009 to September 2010, Mr. Zhou was the vice president of finance and the chief financial officer at Wuxi PharmaTech (Cayman) Inc. Before then, in January 2007, Mr. Zhou joined General Electric (China) Co. Ltd. as a financial manager. Mr. Zhou received his bachelor's degree from Shanghai International Studies University in July 1998.

The Board also announced that, with effect from the Appointment Date, Mr. Zhou has been appointed as the chairman of the Audit Committee, a member of each of the Remuneration Committee and the Nomination Committee.